40162 Federal Register / Vol. 82, No. 163 / Thursday, August 24, 2017 / Notices 

by law to submit deeming applications 

in the specified form and manner on 

behalf of named individuals for review 

and approval, resulting in a ‘‘deeming 

determination’’ that includes associated 

FTCA coverage for these individuals. 

Need and Proposed Use of the 

Information: Deeming applications must 

address certain specified criteria 

required by law in order for deeming 

determinations to be issued, and FTCA 

application forms are critical to BPHC’s 

deeming determination process. These 

forms provide BPHC with the 

information essential for application 

evaluation and determination of 

whether an individual meets the 

requirements for deemed PHS employee 

status for the purposes of FTCA 

coverage. Because the 21st Century 

Cures Act extended FTCA coverage to 

VHPs, BPHC will add new FTCA 

application forms for use by health 

centers applying to sponsor volunteers 

to become volunteer health 

professionals with associated FTCA 

coverage for their activities within the 

scope of deemed employment on behalf 

of the health center. 

Likely Respondents: Respondents 

include Health Center Program funds 

recipients seeking deemed PHS 

employee status on behalf of their 

sponsored individuals for purposes of 

FTCA coverage. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 

disclose or provide the information 

requested. This includes the time 

needed to review instructions; to 

develop, acquire, install and utilize 

technology and systems for the purpose 

of collecting, validating and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information; to search 

data sources; to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. The total annual burden 

hours estimated for this ICR are 

summarized in the table below. 

Total Estimated Annualized Burden 

Hours: 

Form name Number of 

respondents 

Number of 

responses 

per 

respondent 

Total 

responses 

Average 

burden 

per response 

(in hours) 

Total 

burden 

hours 

FTCA Health Center Volunteer Health Professional Program Application ............................................................... 1375 3 4125 2 8250 

Total .............................................................................. 1375 ........................ 4125 ........................ 8250 

HRSA specifically requests comments 

on (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions, (2) the accuracy of the 

estimated burden, (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Amy McNulty, 

Acting Director, Division of the Executive 

Secretariat. 

[FR Doc. 2017–17926 Filed 8–23–17; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy And 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel NIAID Peer Review Meeting. 

Date: September 18–19, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: The William F. Bolger Center, 9600 

Newbridge Drive, Potomac, MD 20854. 

Contact Person: Julio Aliberti, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, DEA/NIAID/NIH/DHHS, 5601 

Fishers Lane, MSC-9823, Rockville, MD 

20852, 301–761–7322, alibertijc@

niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel NIAID Investigator Initiated 

Program Project Applications (P01). 

Date: September 27, 2017. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5601 

Fishers Lane, Rockville, MD 20892 

(Telephone Conference Call). 

Contact Person: Raymond R. Schleef, 

Ph.D., Senior Scientific Review Officer, 

Scientific Review Program, Division of 

Extramural Activities, Room 3E61, National 

Institutes of Health/NIAID, 5601 Fishers 

Lane, MSC 9823, Bethesda, MD 20892–9823, 

(240) 669–5019, schleefrr@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: August 18, 2017. 

Natasha Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–17892 Filed 8–23–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant and/or contract 

proposals applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

and/or contract proposals applications, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel SEER 

Program. 


rmajette on DSKBCKNHB2PROD with NOTICES
Federal Register / Vol. 82, No. 163 / Thursday, August 24, 2017 / Notices 40163 

Date: September 26–27, 2017. 

Time: 8:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue Bethesda, MD 20814. 

Contact Person: Clifford W. Schweinfest, 

Ph.D., Scientific Review Officer, Special 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W108, 

Bethesda, MD 20892–9750, 240–276–6343, 

schweinfestcw@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel Emerging 

Questions in Cancer Systems Biology. 

Date: September 28, 2017. 

Time: 8:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at Chevy Chase 

Pavilion, 4300 Military Road, Washington, 

DC 20015. 

Contact Person: Eun Ah Cho, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W104, Bethesda, MD 

20892–9750, 240–276–6342, choe@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Initial Review Group Subcommittee 

J—Career Development. 

Date: October 17–18, 2017. 

Time: 6:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Tushar Deb, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W624, Bethesda, MD 20892–9750, 

240–276–6132, tushar.deb@nih.gov. 

Name of Committee: National Cancer 

Institute Initial Review Group Subcommittee 

F—Institutional Training and Education. 

Date: October 23–24, 2017. 

Time: 7:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Timothy C. Meeker, M.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W624, Bethesda, MD 20892–9750, 

240–276–6464, meekert@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: August 18, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–17891 Filed 8–23–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Center for Substance Abuse 

Prevention; Notice of Meeting 

Pursuant to Public Law 92–463, 

notice is hereby given that the 

Substance Abuse and Mental Health 

Services Administration’s (SAMHSA) 

Center for Substance Abuse Prevention 

(CSAP) Drug Testing Advisory Board 

(DTAB) will meet in person and via web 

conference on September 19, 2017, from 

9:30am to 5:00pm EDT and September 

20, 2017, from 9:30am to 2:00pm EDT. 

The Board will meet in open session 

on September 19, 2017, from 9:30am to 

12:45pm to provide updates on the 

Mandatory Guidelines for Federal 

Workplace Drug Testing Programs, 

present a study on the degradation of 

deoxyribose nucleic acid (DNA) in urine 

and oral fluid specimens, results from 

the opioid implementation performance 

testing (PT) samples, lessons learned 

from the pilot PT program for oral fluid, 

and the detection of opioid 

glucuronides in drug user hair. Public 

comments are welcome. If you intend to 

provide public comments, please 

register and provide a summary of your 

comments to the contact listed below. 

The Division of Workplace Programs 

will review public comments to ensure 

that they address the topics scheduled 

to be discussed during the meeting and 

adhere to the meeting’s established time 

limits for public comments. 

The board will meet in closed session 

on September 19, 2017, from 2:00pm to 

5:00pm EDT and on September 20, 

2017, from 9:30am to 2:00pm EDT to 

hear about current confidential practices 

in the hair testing industry and to 

discuss proposed revisions of the Oral 

Fluid Mandatory Guidelines for Federal 

Workplace Drug Testing Programs. 

These portions of the meeting are closed 

to the public as determined by the 

Administrator, SAMHSA, in accordance 

with 5 U.S.C. 552b(c)(4) and (9)(B), and 

5 U.S.C. App. 2, Section 10(d). 

To obtain the web conference call-in 

numbers and access codes, registration 

can be completed online at http://

snacregister.samhsa.gov/ 

MeetingList.aspx. 

Meeting information and a roster of 

DTAB members may be obtained by 

accessing the SAMHSA Advisory 

Committees Web site, http://

www.samhsa.gov/about-us/advisorycouncils/drug-testing-advisory-boarddtab, or by contacting Brian Makela. 

Committee Name: Substance Abuse and 

Mental Health Services 

Administration’s Center for Substance 

Abuse Prevention Drug Testing 

Advisory Board 

Dates/Time/Type: September 19, 2017, 

from 9:30am to 12:45pm, EDT: Open, 

September 19, 2017, from 2:00pm to 

5:00pm, EDT: Closed, September 20, 

2017, from 9:30am to 2:00pm, EDT: 

Closed 

Place: Parklawn Building, Rooom 5E29, 

5600 Fishers Lane, Rockville, 

Maryland 20857 

Contact: Brian Makela, Division of 

Workplace Programs, 5600 Fishers 

Lane, Room 16N02B, Rockville, 

Maryland 20857, Telephone: 240– 

276–2600, Fax: 240–276–2610, Email: 

brian.makela@samhsa.hhs.gov. 

Brian Makela, 

Chemist, Substance Abuse and Mental Health 

Services Administration. 

[FR Doc. 2017–17963 Filed 8–23–17; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2017–0723] 

Public Workshop on Marine 

Technology and Standards 

AGENCY: Coast Guard, DHS. 

ACTION: Notice; correction. 

SUMMARY: The Coast Guard is correcting 

a notice that appeared in the Federal 

Register of August 8, 2017. The 

document announced an upcoming 

Public Workshop on Marine Technology 

and Standards to be held on October 16 

and 17, 2017 in Washington, DC. The 

document had an incorrect amount for 

the registration fee. 

FOR FURTHER INFORMATION CONTACT: If 

you have questions about this notice, 

contact Wayne Lundy, Office of Design 

and Engineering Standards, USCG, by 

telephone at (202) 372–1379 or email: 

Wayne.M.Lundy@uscg.mil. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of August 8, 2017 (82 

FR 37104), the Coast Guard published a 

notice announcing a Public Workshop 

on Marine Technology and Standards. 


rmajette on DSKBCKNHB2PROD with NOTICES